In summary, adopting an active lifestyle to prevent obesity and related metabolic disorders, getting vaccinated for HBV, ...

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new ...

Some patients are better candidates than others for histotripsy to treat liver tumors, but ultimately, this treatment still ...

Transplantation combined with immunotherapy to cure liver cancer. Hepatocellular carcinoma (HCC) is the most common type of liver cancer in Switzerland and worldwide. Immunotherap ...

Bristol Myers Squibb has won the European Commission's expanded approval of its Opdivo plus Yervoy cancer-drug combination for early use in certain patients with liver cancer. Bristol Myers on Friday ...

Liver cancer often remains undetected until advanced stages. Learn about the causes and how you can protect yourself with ...

Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

The European Commission approved Opdivo plus Yervoy for first-line treatment of advanced liver cancer, citing significant ...

Liver cancer is the fourth most common cancer and the fourth leading cause of cancer-related deaths in the country.

New research reveals distinct epidemiological trends in liver cancer across Mexico, with gender and regional variations ...